- Home
- Labeler Index
- Takeda Pharmaceuticals America, Inc.
- 0944-2814
- NDC Crossover: 0944-2814 Aralast NP
NDC Crossover 0944-2814 Aralast NP
View and Compare Similar Products, Alternatives & Options
NDC Crossover of Similar Products Matching
The Similar Products in this help users find alternative medications and related products based on key similarities in their regulatory status, product name, active ingredients, dosage form, and administration route.
Explore similar products to 0944-2814 – Aralast NP, a plasma derivative. This list includes other cross-matching products that share:
- The same product name: Aralast NP
- OR Generic name: Alpha-1-proteinase Inhibitor (human)
- AND the same Administration Route:
- OR Dosage Form: kit
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Product Type |
---|---|---|---|---|---|---|
0053-7201 | Zemaira | Alpha-1-proteinase Inhibitor Human | Kit | Csl Behring Llc | Plasma Derivative | |
0053-7202 | Zemaira | .alpha.1-proteinase Inhibitor Human | Kit | Csl Behring Llc | Plasma Derivative | |
0053-7203 | Zemaira | .alpha.1-proteinase Inhibitor Human | Kit | Csl Behring Llc | Plasma Derivative | |
0944-2815 | Aralast NP | Alpha-1-proteinase Inhibitor (human) | Kit | Takeda Pharmaceuticals America, Inc. | Plasma Derivative | |
13533-700 | Prolastin-c | Alpha-1-proteinase Inhibitor (human) | Kit | Grifols Usa, Llc | Plasma Derivative | |
13533-703 | Prolastin-c | Alpha-1-proteinase Inhibitor (human) | Kit | Grifols Usa, Llc | Plasma Derivative | |
13533-706 | Prolastin-c | Alpha-1-proteinase Inhibitor (human) | Kit | Grifols Usa, Llc | Plasma Derivative | |
57516-101 | Zemaira | Alpha-1-proteinase Inhibitor Human Kit | Kit | Intravenous | Fisher Clinical Services Inc. | Plasma Derivative |
57516-110 | Zemaira | Alpha-1-proteinase Inhibitor Human Kit | Kit | Intravenous | Fisher Clinical Services Inc. | Plasma Derivative |
57516-113 | Zemaira | Alpha-1-proteinase Inhibitor Human Kit | Kit | Intravenous | Fisher Clinical Services Inc. | Plasma Derivative |